• Home
  • Blog

Call us today! +1 (352) 353-0052

Find our Location
info@derivatixcapital.com
Login

Login
Derivatix Capital ManagementDerivatix Capital Management
  • Home
  • Blog

Derivatix Quarterly Report: 2022-Q2 as of Jun. 30th, 2022

Derivatix Quarterly Report: 2022-Q2 as of Jun. 30th, 2022

Derivatix Quarterly Report: 2022-Q2 as of Jun. 30th, 2022

July 17, 2022 Uncategorized

Summer is here ladies and gentlemen. Enjoy it before it goes fast….

 

2022-Q2 Market Summary*:

Recession fears and an accelerated Federal Reserve (Fed) interest rate hiking trajectory weighed on markets during the second quarter, resulting in the weakest first half performance since 1970. Supply shocks and robust U.S. consumer demand kept inflation and the Fed in the spotlight. But higher inflation and the sharp rise in yields are taking their toll, with consumer and manufacturing data beginning to show signs of deterioration.

 

Derivatix Performance:

The S&P 500 Index and NASDAQ declined -16.4% and -22.7%, respectively in Q2, while dropping -20.6% and -29.6%, respectively during the first half of 2022. During this tough period, we managed to observe the majority of the market pressure, thanks to our protections in place, to limit the decline levels to -8.10% for the Q2 and -11.1% for the year (Net after all fees).

Looking at the long-term performance, Derivatix experienced a moderate -2.15% decline in the last 12 months while the S&P 500 Index and NASDAQ dropped -11.9% and -20.9%, respectively meantime. Entering the second half of the year, we continue to protect the principal in the first place while looking for signs of strength and recovery in the overall market

 

Source *: Global X

Share
1

You also might be interested in

Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021

Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021

Mar 9, 2021

2021-Q1 Market Summary*: U.S. equities reversed losses and staged a[...]

Derivatix Quarterly Report: Mid 2019-Q4 as of Oct. 15th, 2019

Derivatix Quarterly Report: Mid 2019-Q4 as of Oct. 15th, 2019

Nov 28, 2019

It is the Thanksgiving weekend in the US where most[...]

Derivatix monthly report: Month 26 and 27 as of Nov. 30, 2017

Nov 30, 2017

The market has changed, so do we… We are very[...]

Recent Posts

  • Derivatix Quarterly Report: 2025-Q1 as of Mar. 31, 2025
  • Derivatix Quarterly Report: 2024-Q4 as of Dec. 31, 2024
  • Derivatix Quarterly Report: 2024-Q3 as of Sep. 30, 2024
  • Derivatix Quarterly Report: 2024-Q2 as of Jun. 30, 2024
  • Derivatix Quarterly Report: 2024-Q1 as of Mar. 31, 2024
  • Derivatix Quarterly Report: 2023-Q4 as of Dec. 31, 2023
  • Derivatix Quarterly Report: 2023-Q3 as of Sep. 30, 2023
  • Derivatix Quarterly Report: 2023-Q2 as of Jun. 30, 2023

Recent Comments

    Archives

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent Comments

    Find us on

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Send Message

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.

    Contact Info

    • Derivatix Capital Management
    • +1 (352) 353-0052
    • info@derivatixcapital.com
    • derivatixcapital.com

    Fresh from blog

    • Derivatix Quarterly Report: 2025-Q1 as of Mar. 31, 2025
    • Derivatix Quarterly Report: 2024-Q4 as of Dec. 31, 2024
    • Derivatix Quarterly Report: 2024-Q3 as of Sep. 30, 2024
    • Derivatix Quarterly Report: 2024-Q2 as of Jun. 30, 2024
    • Derivatix Quarterly Report: 2024-Q1 as of Mar. 31, 2024
    • Derivatix Quarterly Report: 2023-Q4 as of Dec. 31, 2023

    © 2025 — Derivatix Capital Management.

    • Home
    • Blog
    Prev Next

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.